Yale University’s Strategic Investment in Vera Therapeutics Inc: A 32.26% Portfolio Stake
This article first appeared on GuruFocus.
Yale University (Trades, Portfolio) recently submitted its 13F filing for the third quarter of 2025, offering a glimpse into its strategic investment decisions during this period. The Yale Investment Office is dedicated to achieving high inflation-adjusted returns to support the university’s current and future needs. Their approach involves establishing a risk-adjusted asset allocation and forming long-term partnerships with managers who provide deep analytical insights and enhance the operations of both public and private businesses. Yale’s portfolio is crafted using a blend of academic theory and market judgment, with a theoretical framework based on mean-variance analysis, a concept…
